Daurismo glasdegib

Fact of Medicine

  • Brand Name: Daurismo
  • Innovator Brand Name: Daurismo
  • API: Glasdegib
  • Packaging: 30/60 Tablets
  • Strength: 25/100mg
  • Manufacturer Name: Pfizer
Get Price
Categories: ,


Uses of medication: Daurismo (Glasdegib) is used together with low-dose cytarabine, for the treatment of newly-diagnosed adult patients (aged >75 years older) with acute myeloid leukemia (AML).

Dosage: The recommended glasdegib dose is 100mg orally once in a day either with or without food on days 1’st to 28’th together with cytarabine 20mg subcutaneously twice in a day on days 1’st to 10’th of each 28-day cycle. Glasdegib tablets should be administered at about the same time each day, even without splitting or crushing.

Treatment Reactions: The most commonly reported glasdegib side effects include:

  • Rash
  • Anemia
  • Fatigue
  • Hemorrhage
  • Nausea
  • Edema
  • Thrombocytopenia
  • Dyspnea
  • Decreased appetite
  • Dysgeusia
  • Mucositis
  • Constipation
  • Febrile neutropenia
  • Musculoskeletal pain

Warning & Precautions

  • The glasdegib uses should be avoided in patients with the comorbidities of severe renal impairment or moderate to severe hepatic impairment.
  • Donating blood or blood products while on glasdegib 100 mg and for at least 30 days following the last dose.
  • Semen shouldn’t be donated while on daurismo 100 mg treatment and for at least 30 days after the last dose.
  • Women with childbearing potential and taking treatment with daurismo tablets should avoid becoming pregnant.
  • Do not breastfeed or provide breast milk to infants/children while taking glasdegib tablets and for at least 30 days following the last dose.

More Info.

Storage: Daurismo (Glasdegib) tablets should be stored at temperature 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). Tablets should be stored at room temperature away from the moisture as well as heat.

Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship DAURISMO at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the DAURISMO Tablets.

Buying Procedure: In order to buy DAURISMO, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp number +919310090915 or an Email to us at: info@theindianpharma.com along with your ID Proof, Valid Prescription Letter and Medical Reports.

Conclusion: Glasdegib/Low-dose cytarabine resulted in an improvement in OS and ORR compared to low-dose cytarabine alone and may be a potential treatment option for newly diagnosed patients with AML who are unfit for the intensive chemotherapy.

Commonly Asked Questions

What does Daurismo contain as an active substance?

The medication Daurismo specifically contains the active substance Glasdegib.

From which class of drug Glasdegib belongs?

Glasdegib basically belongs to a class of drugs named hedgehog pathway inhibitors.

How does Glasdegib act?

As a small molecule inhibitor of the sonic hedgehog, which is a protein overexpressed in the several types of cancer. Glasdegib acts in order to inhibit the sonic hedgehog receptor smoothened (SMO).

How much does daurismo cost?

The daurismo price in India may vary depending on the wholesaler/pharmacy you visit. Cost for the daurismo 25 mg is around 14,03,280 INR for a supply of 60 tablets.

Where can I get Glasdegib at the best price?

In order to get the best glasdegib price, always buy this medication from that Pharmaceutical Wholesaler Company which is WHO-GDP and ISO certified.

Can I get Glasdegib (Daurismo) even if I am not based in India?

The Indian Pharma helps patients in accessing or importing Glasdegib (Daurismo), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.

Send your inquiry to find Daurismo (Glasdegib Tablets) in UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia, Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.